For the Inventor, By the Inventor

Enter inventor name

Birchwood, MN, United States of America

Hugh McTavish

USPTO Granted Patents = 26 (Patent Applications = 7)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 1.3

ph-index = 6

Forward Citations = 94(Granted Patents)

Location History:

Saint Paul, MN (US) (2002)
Birchwood, MN (US) (2004 - 2015)
Pine Springs, MN (US) (2015 - 2024)

Company Filing History:

Igf Oncology, LLC

Novus Energy LLC

4. 2 out of 2,308

University of Minnesota

Strokemaster Backboard, LLC

6. 1 out of 836

University of Arkansas

Squarex Pharmaceutical Corporation

Bioventures, LLC

10. 5 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2024

Loading Chart...

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12128098 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2024-10-29),

2. 11957783 - Topical immunosensitizers to treat viral and fungal infections (2024-04-16),

3. 11324834 - Insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome (2022-05-10),

4. 10967049 - Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof (2021-04-06),

5. 10940197 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2021-03-09),

6. 10744084 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2020-08-18),

7. 10391147 - Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof (2019-08-27),

8. 10245314 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2019-04-02),

9. 9801923 - Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof (2017-10-31),

10. 9675671 - Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof (2017-06-13),

11. 9205065 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2015-12-08),

12. 9011880 - Compounds and methods for treating cancer (2015-04-21),

13. 8920777 - Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer (2014-12-30),

14. 8501906 - Compounds and methods for treating cancer (2013-08-06),

15. 8017102 - Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer (2011-09-13),

Title: The Inventor Profile of Hugh McTavish

Introduction: Hugh McTavish is a renowned inventor based in Birchwood, Minnesota. With a passion for innovation and problem-solving, he has made significant contributions to various fields through his inventive spirit.

Latest Patents: Hugh McTavish holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced medical devices. His recent patents focus on enhancing efficiency and sustainability in everyday processes.

Career Highlights: Throughout his career, Hugh McTavish has been recognized for his groundbreaking inventions that have improved the quality of life for many. His dedication to creating solutions for complex challenges has led to numerous successful ventures.

Collaborations: Hugh McTavish has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work in multidisciplinary teams has resulted in innovative products that have made a positive impact on society.

Conclusion: In conclusion, Hugh McTavish's innovative mindset and commitment to pushing the boundaries of technology have established him as a prominent figure in the world of inventions. His work continues to inspire future generations of inventors to think creatively and strive for excellence in their pursuits.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…